Drug Type CAR-T |
Synonyms PD1-BCMA-CART(BRL medicine), PD1-BCMA-CART-Bioray Laboratories |
Target |
Action inhibitors |
Mechanism PSMA inhibitors(Prostate-specific membrane antigen inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Refractory Multiple Myeloma | Clinical | China | 01 Mar 2024 | |
Relapse multiple myeloma | Clinical | China | 01 Mar 2024 |